v3.25.4
Ordinary Shares and Equity Incentive Plan (Tables)
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock by Class
We have the following ordinary shares reserved for future issuance:
As of December 31,
2025
2024
Warrants issued to customers
499,500 499,500 
Share options and RSUs issued and outstanding under the 2013 Plan9,590,835 12,892,506 
Share options and RSUs issued and outstanding under the 2021 Plan13,095,118 14,488,408 
Remaining shares available for future issuance under the 2021 Plan12,733,513 12,928,337 
Total ordinary shares reserved35,918,96640,808,751
Share-based Payment Arrangement, Option, Activity A summary of share options under our equity incentive plan and related information is as follows:
Share Options Outstanding
Outstanding Share OptionsWeighted-Average Exercise
Price
Weighted-Average Remaining Contractual Life (Years)Aggregate Intrinsic
Value
(in thousands, except share, life and per share data)
Balance as of December 31, 20247,946,639 $2.49 4.6$18,280 
Options exercised(2,645,197)$1.94 
Options forfeited(22,839)$5.50 
Balance as of December 31, 20255,278,603 $2.74 3.8$12,087 
Exercisable as of December 31, 20255,243,915 $2.74 3.8$12,044 
Schedule of Unvested Restricted Stock Units Roll Forward
A summary of RSU activity, including activity under our equity incentive plan, and related information is as follows:
Number of SharesWeighted-Average
Grant-Date Fair Value
Per Share
Unvested as of December 31, 2024
19,434,183 
$
7.49 
Granted
8,587,279 
$5.14 
Vested(1)
(8,264,607)
$6.46 
Forfeited
(2,349,505)
$5.22 
Unvested as of December 31, 2025
17,407,350 
$7.13 
(1)A portion of the shares that vested were withheld by us to satisfy the tax obligations of the recipients. During the year ended December 31, 2025, a total of 1,989,883 RSUs were canceled to satisfy tax obligations, resulting in net issuance of 6,274,724 Class A ordinary shares.
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
Share-based compensation expense by line item in the consolidated statements of operations is summarized as follows:
Year Ended December 31,
202520242023
(in thousands)
Cost of revenue$738 $765 $770 
Research and development12,621 13,061 13,152 
Sales and marketing16,013 18,506 19,420 
General and administrative22,254 25,499 29,068 
Total share-based compensation expense$51,626 $57,831 $62,410